Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.
Smits MM, Tonneijck L, Muskiet MH, Hoekstra T, Kramer MH, Pieters IC, Cahen DL, Diamant M, van Raalte DH. Smits MM, et al. Among authors: hoekstra t. BMJ Open. 2015 Nov 19;5(11):e009579. doi: 10.1136/bmjopen-2015-009579. BMJ Open. 2015. PMID: 26586327 Free PMC article. Clinical Trial.
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.
Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ, Diamant M, Joles JA, van Raalte DH. Tonneijck L, et al. Among authors: hoekstra t. Diabetologia. 2016 Jul;59(7):1412-1421. doi: 10.1007/s00125-016-3938-z. Epub 2016 Apr 1. Diabetologia. 2016. PMID: 27038451 Free PMC article. Clinical Trial.
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial.
van Raalte DH, Bunck MC, Smits MM, Hoekstra T, Cornér A, Diamant M, Eliasson B, Marja-RiittaTaskinen, Heine RJ, Smith U, HanneleYki-Järvinen, Mari A. van Raalte DH, et al. Among authors: hoekstra t. Eur J Endocrinol. 2016 Oct;175(4):345-52. doi: 10.1530/EJE-16-0286. Epub 2016 Jul 27. Eur J Endocrinol. 2016. PMID: 27466218 Clinical Trial.
GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Smits MM, Tonneijck L, Muskiet MH, Hoekstra T, Kramer MH, Diamant M, Serné EH, van Raalte DH. Smits MM, et al. Among authors: hoekstra t. Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2125-32. doi: 10.1161/ATVBAHA.116.307930. Epub 2016 Aug 25. Arterioscler Thromb Vasc Biol. 2016. PMID: 27562916 Clinical Trial.
Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Tonneijck L, Smits MM, Muskiet MH, Hoekstra T, Kramer MH, Danser AH, Ter Wee PM, Diamant M, Joles JA, van Raalte DH. Tonneijck L, et al. Among authors: hoekstra t. Diabetes Care. 2016 Nov;39(11):2042-2050. doi: 10.2337/dc16-1371. Epub 2016 Sep 1. Diabetes Care. 2016. PMID: 27585605 Clinical Trial.
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial.
Smits MM, Tonneijck L, Muskiet MH, Kramer MH, Pouwels PJ, Pieters-van den Bos IC, Hoekstra T, Diamant M, van Raalte DH, Cahen DL. Smits MM, et al. Among authors: hoekstra t. Diabetologia. 2016 Dec;59(12):2588-2593. doi: 10.1007/s00125-016-4100-7. Epub 2016 Sep 15. Diabetologia. 2016. PMID: 27627981 Free PMC article. Clinical Trial.
Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial.
Smits MM, Tonneijck L, Muskiet MH, Kramer MH, Pieters-van den Bos IC, Vendrik KE, Hoekstra T, Bruno MJ, Diamant M, van Raalte DH, Cahen DL. Smits MM, et al. Among authors: hoekstra t. Diabetes Care. 2017 Mar;40(3):301-308. doi: 10.2337/dc16-0836. Epub 2016 Dec 20. Diabetes Care. 2017. PMID: 27998910 Clinical Trial.
238 results